Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a home exercise program ease COPD symptoms?

NCT ID NCT06954948

Symptom relief Sponsor: Hawler Medical University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a home-based pulmonary rehabilitation programme could help people with COPD in areas with limited healthcare resources. 128 participants either received the 8-week home programme (exercise, education, and phone support) or standard care. Researchers measured changes in flare-ups, walking distance, and breathlessness to see if the home programme improved outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulmonary rehabilitation (exercise and education programme)
What this could lead to
If it works, this could offer a practical, low-cost way for people with COPD to manage breathlessness and improve daily life at home.
What could go wrong
This is a completed trial with 128 participants, but results are not yet widely confirmed. The programme requires motivation and may not work for everyone with severe COPD.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

128 people

The number who actually took part.

Started

Sep 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 80 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical diagnosis of COPD, confirmed by spirometry and pulmonologist * Age ≥40 years (to avoid recruiting participants with asthma rather than COPD) * Current or previous smoker (≥10 packs per year) * Confidence in using the proposed pulmonary rehabilitation (PR) system * Kurdish language fluency * Willingness to participate and sign an informed consent form. Exclusion Criteria: * patients with pulmonary hypertension * patients with movement disorders and/or a history of falls * patients with severe sensory or cognitive impairment * patients with symptomatic ischemic heart disease * patients with musculoskeletal degenerative disease * Patients out site of the city or inability to be contacted

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COPD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic obstructive pulmonary disease COPD, severe early onset

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COPD

Contacts and locations

Locations

  • Hawler Medical University

    Erbil, Kurdistan, 44001, Iraq

More trials for these conditions

Other studies related to the condition(s) this trial covers.